利益相反:ビジネス、法、医療と公共政策<br>Conflicts of Interest : Challenges and Solutions in Business, Law, Medicine, and Public Policy

個数:

利益相反:ビジネス、法、医療と公共政策
Conflicts of Interest : Challenges and Solutions in Business, Law, Medicine, and Public Policy

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合、分割発送となる場合がございます。
    3. 美品のご指定は承りかねます。
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 314 p.
  • 言語 ENG
  • 商品コード 9780521844390
  • DDC分類 174

基本説明

Legal and policy responses are considered, some of which (e.g., disclosure) are shown to backfire and even fail.

Full Description

This collection explores the subject of conflicts of interest. It investigates how to manage conflicts of interest, how they can affect well-meaning professionals, and how they can limit the effectiveness of corporate boards, undermine professional ethics, and corrupt expert opinion. Legal and policy responses are considered, some of which (e.g. disclosure) are shown to backfire and even fail. The results offer a sobering prognosis for professional ethics and for anyone who relies on professionals who have conflicts of interest. The contributors are leading authorities on the subject in the fields of law, medicine, management, public policy, and psychology. The nuances of the problems posed by conflicts of interest will be highlighted for readers in an effort to demonstrate the many ways that structuring incentives can affect decision making and organizations' financial well-being.

Contents

List of contributors; Acknowledgements; Introduction Don A. Moore, George Loewenstein, Daylian M. Cain, and Max H. Bazerman; Part I. Business: 1. Managing conflicts of interest within organizations: does activating social values change the impact of self-interest on behavior? Tom R. Tyler; 2. Commentary: on Tyler's 'Managing conflicts of interest within organizations' Robyn Dawes; 3. A review of experimental and archival conflicts-of-interest research in auditing Mark W. Nelson; 4. Commentary: conflicts of interest in accounting Don A. Moore; 5. Bounded ethicality as a psychological barrier to recognizing conflicts of interest Dolly Chugh, Max H. Bazerman and Mahzarin R. Banaji; 6. Commentary: bounded ethicality and conflicts of interest Ann E. Tenbrunsel; 7. Coming clean but playing dirtier: the shortcomings of disclosure as a solution to conflicts of interest Daylian M. Cain, George Loewenstein and Don A. Moore; 8. Commentary: psychologically naive assumptions about the perils of conflicts of interest Dale T. Miller; Part II. Medicine: 9. Physicians' financial ties with the pharmaceutical industry: a critical element of a formidable marketing network Jerome P. Kassirer; 10. Commentary: how did we get into this mess? Peter A. Ubel; 11. Why are (some) conflicts of interest in medicine so uniquely vexing? Andrew Stark; 12. Commentary: financial conflicts of interest and the identity of academic medicine Scott Y. H. Kim; Part III. Law: 13. Legal responses to conflicts of interest Samuel Issacharoff; 14. Commentary: conflicts of interest begin where principal-agent problems end George Loewenstein; 15. Conflicts of interest and strategic ignorance of harm Jason Dana; 16. Commentary: strategic ignorance of harm Daylian M. Cain; Part IV. Public Policy: 17. Conflicts of interest in public policy research Robert J. MacCoun; 18. Commentary: conflicts of interest in policy analysis: compliant pawns in their game? Baruch Fischhoff; 19. Conflict of interest as an objection to consequentialist moral reasoning Robert H. Frank; 20. Commentary: conflict of interest as a threat to consequentialist reasoning David M. Messick; Index.

最近チェックした商品